VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,454,792 | -59.6% | 261,987 | +5.8% | 0.00% | -57.1% |
Q2 2023 | $6,073,946 | +110799.1% | 247,613 | +5.2% | 0.01% | 0.0% |
Q1 2023 | $5,477 | -2.0% | 235,388 | +6.6% | 0.01% | -12.5% |
Q4 2022 | $5,586 | -99.9% | 220,722 | -0.7% | 0.01% | +33.3% |
Q3 2022 | $4,287,000 | -21.6% | 222,367 | +3.5% | 0.01% | -25.0% |
Q2 2022 | $5,471,000 | +228.4% | 214,806 | +231.6% | 0.01% | +300.0% |
Q1 2022 | $1,666,000 | -37.7% | 64,769 | +1.4% | 0.00% | -33.3% |
Q4 2021 | $2,674,000 | -4.5% | 63,854 | -0.7% | 0.00% | -25.0% |
Q3 2021 | $2,800,000 | -5.9% | 64,334 | +2.2% | 0.00% | 0.0% |
Q2 2021 | $2,976,000 | -3.9% | 62,951 | +4.2% | 0.00% | 0.0% |
Q1 2021 | $3,096,000 | +76.7% | 60,385 | -7.7% | 0.00% | +100.0% |
Q4 2020 | $1,752,000 | -16.5% | 65,435 | +7.0% | 0.00% | -33.3% |
Q3 2020 | $2,099,000 | -25.5% | 61,128 | -11.2% | 0.00% | -40.0% |
Q2 2020 | $2,819,000 | +678.7% | 68,807 | +552.0% | 0.01% | +400.0% |
Q1 2020 | $362,000 | – | 10,554 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |